Loading...
Loading...

by Synokem Pharmaceuticals Ltd· 10s
SKU: 1173642
You save ₹66 on this order
Inclusive of all taxes
TNIB ER TABLET contains Tofacitinib, a disease-modifying anti-rheumatic drug
(DMARD) belonging to the Janus kinase (JAK) inhibitors class. It is used to
manage moderate to severe inflammatory conditions including rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
TNIB ER TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3), blocking the
signaling pathways that lead to inflammation and immune system overactivation.
This results in reduced pain, swelling, and tissue damage in autoimmune
conditions.
Take TNIB ER TABLET exactly as prescribed by your doctor, usually once or twice
daily. Swallow the tablet whole with water, with or without food. Do not crush
or chew the tablet. Consistent dosing at the same time each day helps maintain
symptom control.
Inform your doctor if you have infections, liver or kidney disease, or a history
of tuberculosis before starting TNIB ER TABLET. Pregnant or breastfeeding women
should consult their healthcare provider before use.
Avoid live vaccines without medical approval while taking this medication.
Regular monitoring of blood counts and liver function is necessary during
treatment. The common side effects are headache, dizziness, respiratory
infections, increased cholesterol levels, nausea, diarrhea, abdominal pain and
increased risk of serious infections.
TNIB ER TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3), blocking the
signaling pathways that lead to inflammation and immune system overactivation.
This results in reduced pain, swelling, and tissue damage in autoimmune
conditions.
TNIB ER TABLET can be taken with or without food according to medical sources.
It is recommended to take the tablet at the same time each day to maintain
consistent drug levels and o
may help reduce potential stomach upset, but it is not mandatory.
It is not safe to crush, chew, break, or split TNIB ER TABLET. The tablet should
be swallowed whole with water to ensure proper absor
If you miss a dose, take it as soon as you remember unless it is almost time for
your next scheduled dose. In that case, skip the missed dose and continue with
your regular dosing schedule. Do not take a double dose to make up for the
missed one, as this could increase the risk of side effects.
If you or anyone else accidentally take too much of TNIB ER TABLET, consult your
doctor immediately or visit the nearby hospital.
!### Pregnancy
ContraindicatedTNIB ER TABLET is not recommended for use in pregnant women or women planning to
have a baby. If you are a woman of childbearing age, you should use effective
birth control during management and for at least 4 weeks after the last dose.
!### Breastfeeding
ContraindicatedTNIB ER TABLET is not recommended for use in breastfeeding women.
!### Driving and Using Machines
Use with CautionTNIB ER TABLET does not affect your ability to drive or use machines.
!### Kidney
Use with CautionTNIB ER TABLET should be taken with caution in patients with kidney disease. The
dose will be adjusted by your doctor.
!### Liver
Consult your doctorTNIB ER TABLET is not recommended in patients with severe liver problems such as
cirrhosis (scarring of the liver). It should be used with caution in patients
having other liver diseases such as hepatitis B or hepatitis C. Dose will be
adjusted by your doctor.
!### Allergy
ContraindicatedDo not take TNIB ER TABLET if you are allergic to Tofacitinib or any other
ingredients of this medicine.
!### Lungs
Consult your doctorTNIB ER TABLET is not recommended for use in active tuberculosis. It should be
taken with caution in patients with chronic lung disease or a history of
tuberculosis.
!### Heart Disease
Use with CautionTNIB ER TABLET should be taken with caution in patients with heart diseases such
as heart attack and high blood pressure.
!### Use In Pediatrics
Consult your doctorThe safety and effectiveness of TNIB ER TABLET in children below 2 years of age
have not been established yet.
!### Use In Geriatrics
Use with CautionTNIB ER TABLET should be used with caution in patients above the age of 65 years
of age as they may be at increased risk of infections, heart attack and some
types of cancer.
Before taking TNIB ER TABLET, inform your doctor if you have,
TNIB ER TABLET is not recommended for use if you have:
Maintain a nutritious, well-balanced diet rich in fruits, vegetables, lean
proteins, and whole grains to support overall health and immune function. Stay
well-hydrated to assist medication metabolism and reduce potential
gastrointestinal side effects.
Engage in low-impact exercises such as walking, swimming, or yoga to improve
joint flexibility, muscle strength, and cardiovascular health without
overstressing inflamed joints.
Because TNIB ER TABLET suppresses the immune system, practice good hygiene,
avoid close contact with sick individuals, get recommended vaccinations, and
promptly report signs of infection to your healthcare provider.
Smoking may worsen inflammatory conditions and impair healing, while excessive
alcohol can increase liver stress and gastrointestinal risks. Aim to quit
smoking and limit alcohol intake under medical guidance.
Incorporate relaxation techniques like meditation, deep breathing exercises, or
counselling to reduce stress, which can exacerbate autoimmune symptoms.
Adhere strictly to scheduled blood tests and healthcare appointments to monitor
treatment efficacy and side effects, enabling timely adjustments.
Tuberculosis and Infections:
Patients with active tuberculosis or a history of latent TB should be screened
and managed appropriately before starting TNIB ER TABLET. The drug suppresses
immune response, increasing susce
essential.
Hepatitis
Use caution in patients with a history of hepatitis B or C. Liver function
should be monitored regularly, as TNIB ER TABLET may affect liver enzymes and
exacerbate underlying liver conditions.
Grapefruit products and St. John’s Wort can affect metabolism and should be
avoided.
| Drug | Tofacitinib |
| Pharmacological Category | Janus Kinase Inhibitors |
| Therapeutic Indication | Inflammatory diseases |
| Dosage Forms | Tablet |
Briefly contrast TNIB ER TABLET with older DMARDs or biologics regarding
efficacy, side effects, administration ease, or monitoring needs.
TNIB ER TABLET differs from older traditional DMARDs and biologic therapies in
several important ways that contribute to its unique value:
Tofacitinib has demonstrated comparable or superior efficacy in improving arthritis symptoms, physical function, and remission rates compared to classic DMARDs like methotrexate and some biologics such as adalimumab and etanercept. Clinical trials and meta-analyses have shown tofacitinib monotherapy or in combination can lead to higher ACR20/50/70 response rates and better patient-reported outcomes.
Unlike biologics, which require subcutaneous injections or intravenous infusions, TNIB ER TABLET is an oral medication, increasing convenience and potentially improving patient adherence. Oral dosing avoids needle-related anxiety and the need for healthcare facility visits for administration.
While sharing some immunosuppressive risks, tofacitinib shows a tolerability profile that can be more favorable for certain patients, with less injection site reactions and comparable rates of serious adverse events to biologics. GI side effects may be less frequent compared to traditional DMARDs like methotrexate.
TNIB ER TABLET requires regular blood monitoring for blood counts, liver, kidney function, and lipid levels, similar to biologics, but potentially less frequent than complex combination therapies with older DMARDs. This allows targeted safety surveillance while maintaining efficacy.
Tofacitinib’s oral administration can reduce associated healthcare costs like administration fees or facility visits, improving total cost-effectiveness for some patients despite the drug's retail price.
A: No, it helps control symptoms and slow disease progression but is not a cure.
A: It may take several weeks to observe full therapeutic effects.
A: Long-term use requires regular medical supervision due to potential risks.
A: TNIB ER TABLET contains tofacitinib, which belongs to the group of medicines
called immunosuppressants. It is used to manage inflammatory diseases such as
rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and ankylosing
spondylitis. It is used together with medicines such as methotrexate when
previous rheumatoid arthritis management was not sufficient or was not well
tolerated.
A: TNIB ER TABLET can lower the ability of your immune system to fight
infections. Do not start stating this medicine if you have any kind of
infection, a history of infection or are at risk of developing one.
A: TNIB ER TABLET is not recommended for use by pregnant or breastfeeding women.
If you are a woman of childbearing age, effective birth control methods must be
used during management with this medicine and for at least 4 weeks after the
last dose. Tell your doctor immediately if you become pregnant while taking the
medicine.
A: TNIB ER TABLET is used to manage polyarticular juvenile idiopathic arthritis
and juvenile psoriatic arthritis, which cause pain and inflammation of joints in
children over 2 years of age. Ask for your doctor?s advice before giving it to
your child.
A: Your doctor might check you regularly for the levels of white blood cells and
red blood cells in your blood while you take TNIB ER TABLET.
A: If you forgot to take a dose of TNIB ER TABLET, then do not take the missed
dose between meals. Continue taking your medication as usual until your next
scheduled dose and meal. Do not take a double dose to make up for a forgotten
dose.
A: Patients aged 65 years and older may be at increased risk of infections,
heart attacks and some types of cancer; therefore, it should be used with
caution in patients above the age of 65 years.
TNIB ER TABLET contains Tofacitinib, a disease-modifying anti-rheumatic drug
(DMARD) belonging to the Janus kinase (JAK) inhibitors class. It is used to
manage moderate to severe inflammatory conditions including rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
TNIB ER TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3), blocking the
signaling pathways that lead to inflammation and immune system overactivation.
This results in reduced pain, swelling, and tissue damage in autoimmune
conditions.
Take TNIB ER TABLET exactly as prescribed by your doctor, usually once or twice
daily. Swallow the tablet whole with water, with or without food. Do not crush
or chew the tablet. Consistent dosing at the same time each day helps maintain
symptom control.
Inform your doctor if you have infections, liver or kidney disease, or a history
of tuberculosis before starting TNIB ER TABLET. Pregnant or breastfeeding women
should consult their healthcare provider before use.
Avoid live vaccines without medical approval while taking this medication.
Regular monitoring of blood counts and liver function is necessary during
treatment. The common side effects are headache, dizziness, respiratory
infections, increased cholesterol levels, nausea, diarrhea, abdominal pain and
increased risk of serious infections.
TNIB ER TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3), blocking the
signaling pathways that lead to inflammation and immune system overactivation.
This results in reduced pain, swelling, and tissue damage in autoimmune
conditions.
TNIB ER TABLET can be taken with or without food according to medical sources.
It is recommended to take the tablet at the same time each day to maintain
consistent drug levels and o
may help reduce potential stomach upset, but it is not mandatory.
It is not safe to crush, chew, break, or split TNIB ER TABLET. The tablet should
be swallowed whole with water to ensure proper absor
If you miss a dose, take it as soon as you remember unless it is almost time for
your next scheduled dose. In that case, skip the missed dose and continue with
your regular dosing schedule. Do not take a double dose to make up for the
missed one, as this could increase the risk of side effects.
If you or anyone else accidentally take too much of TNIB ER TABLET, consult your
doctor immediately or visit the nearby hospital.
!### Pregnancy
ContraindicatedTNIB ER TABLET is not recommended for use in pregnant women or women planning to
have a baby. If you are a woman of childbearing age, you should use effective
birth control during management and for at least 4 weeks after the last dose.
!### Breastfeeding
ContraindicatedTNIB ER TABLET is not recommended for use in breastfeeding women.
!### Driving and Using Machines
Use with CautionTNIB ER TABLET does not affect your ability to drive or use machines.
!### Kidney
Use with CautionTNIB ER TABLET should be taken with caution in patients with kidney disease. The
dose will be adjusted by your doctor.
!### Liver
Consult your doctorTNIB ER TABLET is not recommended in patients with severe liver problems such as
cirrhosis (scarring of the liver). It should be used with caution in patients
having other liver diseases such as hepatitis B or hepatitis C. Dose will be
adjusted by your doctor.
!### Allergy
ContraindicatedDo not take TNIB ER TABLET if you are allergic to Tofacitinib or any other
ingredients of this medicine.
!### Lungs
Consult your doctorTNIB ER TABLET is not recommended for use in active tuberculosis. It should be
taken with caution in patients with chronic lung disease or a history of
tuberculosis.
!### Heart Disease
Use with CautionTNIB ER TABLET should be taken with caution in patients with heart diseases such
as heart attack and high blood pressure.
!### Use In Pediatrics
Consult your doctorThe safety and effectiveness of TNIB ER TABLET in children below 2 years of age
have not been established yet.
!### Use In Geriatrics
Use with CautionTNIB ER TABLET should be used with caution in patients above the age of 65 years
of age as they may be at increased risk of infections, heart attack and some
types of cancer.
Before taking TNIB ER TABLET, inform your doctor if you have,
TNIB ER TABLET is not recommended for use if you have:
Maintain a nutritious, well-balanced diet rich in fruits, vegetables, lean
proteins, and whole grains to support overall health and immune function. Stay
well-hydrated to assist medication metabolism and reduce potential
gastrointestinal side effects.
Engage in low-impact exercises such as walking, swimming, or yoga to improve
joint flexibility, muscle strength, and cardiovascular health without
overstressing inflamed joints.
Because TNIB ER TABLET suppresses the immune system, practice good hygiene,
avoid close contact with sick individuals, get recommended vaccinations, and
promptly report signs of infection to your healthcare provider.
Smoking may worsen inflammatory conditions and impair healing, while excessive
alcohol can increase liver stress and gastrointestinal risks. Aim to quit
smoking and limit alcohol intake under medical guidance.
Incorporate relaxation techniques like meditation, deep breathing exercises, or
counselling to reduce stress, which can exacerbate autoimmune symptoms.
Adhere strictly to scheduled blood tests and healthcare appointments to monitor
treatment efficacy and side effects, enabling timely adjustments.
Tuberculosis and Infections:
Patients with active tuberculosis or a history of latent TB should be screened
and managed appropriately before starting TNIB ER TABLET. The drug suppresses
immune response, increasing susce
essential.
Hepatitis
Use caution in patients with a history of hepatitis B or C. Liver function
should be monitored regularly, as TNIB ER TABLET may affect liver enzymes and
exacerbate underlying liver conditions.
Grapefruit products and St. John’s Wort can affect metabolism and should be
avoided.
| Drug | Tofacitinib |
| Pharmacological Category | Janus Kinase Inhibitors |
| Therapeutic Indication | Inflammatory diseases |
| Dosage Forms | Tablet |
Briefly contrast TNIB ER TABLET with older DMARDs or biologics regarding
efficacy, side effects, administration ease, or monitoring needs.
TNIB ER TABLET differs from older traditional DMARDs and biologic therapies in
several important ways that contribute to its unique value:
Tofacitinib has demonstrated comparable or superior efficacy in improving arthritis symptoms, physical function, and remission rates compared to classic DMARDs like methotrexate and some biologics such as adalimumab and etanercept. Clinical trials and meta-analyses have shown tofacitinib monotherapy or in combination can lead to higher ACR20/50/70 response rates and better patient-reported outcomes.
Unlike biologics, which require subcutaneous injections or intravenous infusions, TNIB ER TABLET is an oral medication, increasing convenience and potentially improving patient adherence. Oral dosing avoids needle-related anxiety and the need for healthcare facility visits for administration.
While sharing some immunosuppressive risks, tofacitinib shows a tolerability profile that can be more favorable for certain patients, with less injection site reactions and comparable rates of serious adverse events to biologics. GI side effects may be less frequent compared to traditional DMARDs like methotrexate.
TNIB ER TABLET requires regular blood monitoring for blood counts, liver, kidney function, and lipid levels, similar to biologics, but potentially less frequent than complex combination therapies with older DMARDs. This allows targeted safety surveillance while maintaining efficacy.
Tofacitinib’s oral administration can reduce associated healthcare costs like administration fees or facility visits, improving total cost-effectiveness for some patients despite the drug's retail price.
A: No, it helps control symptoms and slow disease progression but is not a cure.
A: It may take several weeks to observe full therapeutic effects.
A: Long-term use requires regular medical supervision due to potential risks.
A: TNIB ER TABLET contains tofacitinib, which belongs to the group of medicines
called immunosuppressants. It is used to manage inflammatory diseases such as
rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and ankylosing
spondylitis. It is used together with medicines such as methotrexate when
previous rheumatoid arthritis management was not sufficient or was not well
tolerated.
A: TNIB ER TABLET can lower the ability of your immune system to fight
infections. Do not start stating this medicine if you have any kind of
infection, a history of infection or are at risk of developing one.
A: TNIB ER TABLET is not recommended for use by pregnant or breastfeeding women.
If you are a woman of childbearing age, effective birth control methods must be
used during management with this medicine and for at least 4 weeks after the
last dose. Tell your doctor immediately if you become pregnant while taking the
medicine.
A: TNIB ER TABLET is used to manage polyarticular juvenile idiopathic arthritis
and juvenile psoriatic arthritis, which cause pain and inflammation of joints in
children over 2 years of age. Ask for your doctor?s advice before giving it to
your child.
A: Your doctor might check you regularly for the levels of white blood cells and
red blood cells in your blood while you take TNIB ER TABLET.
A: If you forgot to take a dose of TNIB ER TABLET, then do not take the missed
dose between meals. Continue taking your medication as usual until your next
scheduled dose and meal. Do not take a double dose to make up for a forgotten
dose.
A: Patients aged 65 years and older may be at increased risk of infections,
heart attacks and some types of cancer; therefore, it should be used with
caution in patients above the age of 65 years.